While there are no clear diagnostic criteria or biomarkers specific to cancer‐induced cardiac cachexia, most potential biomarkers in the circulation associated with cancer cachexia in general can be promising in the detection of cardiomyopathies, including TNFa, IL‐6, IL‐1b, and IL‐10.28, 49. This evidence concerns the gene IL1B and cancer.